Viewing StudyNCT02927366

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 9:11 AM
Last Modification Date: 2024-10-26 @ 12:11 PM
Study NCT ID: NCT02927366
Status: TERMINATED
Last Update Posted: 2021-01-05
First Post: 2016-10-05
Brief Title: Safety Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Pulmonary Arterial Hypertension
Keywords:
Name View
QCC374 View
Pulmonary hypertension PH View
Increase blood pressure in the pulmonary artery View
Increased blood pressure in the pulmonary vein View
Increased blood pressure in the lung vasculature View
Shortness of breath View
Dizziness View
Fainting View
Leg swelling View
Cough View